Oryzon Genomics S.A. (FRA:ORN)
3.135
+0.025 (0.80%)
At close: Dec 4, 2025
105.44% (1Y)
| Market Cap | 252.33M |
| Revenue (ttm) | 7.36M |
| Net Income (ttm) | -2.76M |
| Shares Out | n/a |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | 246.44 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | n/a |
| Open | 3.135 |
| Previous Close | 3.110 |
| Day's Range | 3.135 - 3.135 |
| 52-Week Range | 1.378 - 3.975 |
| Beta | n/a |
| RSI | 50.17 |
| Earnings Date | Feb 27, 2026 |